DNO ASA (DTNOF) — Earnings Call X-Ray
Our AI read all 25 of DTNOF's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
F
Q4 2024
Calls Analyzed
25
2016–2025
Avg Candor
6.9/9
evasion 3/9
Call-by-call analysis
🔒 Q1 2025 earnings call
2025-05-15
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q1 2025 call grade is ready
The full 37-point AI read of DTNOF's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
F
Q4 2024 earnings call
2025-02-06
Management withdrew guidance against steady demand and contracting margins. The delivery was unusually candid.
Guidance: withdrawnDemand: stableMargins: contractingPricing: under pressureCapex: increasing 4 analysts · 7 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q3 2024 earnings call
2024-11-10
Management lowered guidance against mixed demand signals. The delivery was rich in specifics, frequently evasive.
Guidance: loweredDemand: mixedMargins: stablePricing: raisingCapex: decreasing 4 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C
Q2 2024 earnings call
2024-08-15
Management held guidance steady against steady demand. The delivery was unusually candid, rich in specifics, relaxed under questioning.
Guidance: maintainedDemand: stablePricing: under pressureCapex: increasing 4 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Prepayments growing✓ Volume step-up ahead
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q4 2023 earnings call
2024-02-08
Management raised guidance against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: raisedDemand: stableMargins: contractingPricing: under pressureHeadcount: cuttingCapex: increasing 5 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritableDirection beats results
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q2 2023 earnings call
2023-08-19
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.
Demand: mixedMargins: contractingPricing: under pressureHeadcount: cuttingCapex: decreasing 4 analysts · 10 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Prepayments growing✓ Volume step-up aheadFounder-led
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
YES Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q4 2022 earnings call
2023-02-09
Management lowered guidance against steady demand and contracting margins. The delivery was unusually candid, rich in specifics.
Guidance: loweredDemand: stableMargins: contractingPricing: under pressureCapex: decreasing 4 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsCFO dominates
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
C+
Q2 2022 earnings call
2022-08-14
Management raised guidance against steady demand and contracting margins. The delivery was rich in specifics.
Guidance: raisedDemand: stableMargins: contractingPricing: stableCapex: increasing 2 analysts · 5 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsCFO dominates
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q1 2022 |
2022-05-15 |
B |
maintained | stable | expanding |
7/9 |
2/9 |
| Q4 2021 |
2022-02-10 |
B+ |
raised | accelerating | expanding |
7/9 |
2/9 |
| Q3 2021 |
2021-11-07 |
C+ |
maintained | accelerating | expanding |
7/9 |
3/9 |
| Q4 2020 |
2021-02-12 |
B+ |
raised | accelerating | expanding |
7/9 |
2/9 |
| Q2 2020 |
2020-08-02 |
B+ |
raised | recovering | contracting |
7/9 |
3/9 |
| Q4 2019 |
2020-02-07 |
C+ |
maintained | stable | stable |
7/9 |
2/9 |
| Q2 2019 |
2019-08-02 |
B |
maintained | stable | expanding |
7/9 |
3/9 |
| Q1 2019 |
2019-05-12 |
C+ |
maintained | stable | stable |
7/9 |
4/9 |
| Q4 2018 |
2019-02-08 |
B+ |
raised | stable | expanding |
7/9 |
3/9 |
| Q2 2018 |
2018-08-16 |
B |
maintained | accelerating | expanding |
7/9 |
2/9 |
| Q4 2017 |
2018-02-08 |
A |
raised | stable | expanding |
8/9 |
1/9 |
| Q2 2017 |
2017-08-25 |
B+ |
raised | stable | expanding |
7/9 |
3/9 |
| Q4 2016 |
2017-02-10 |
B |
raised | stable | expanding |
7/9 |
3/9 |
| Q3 2016 |
2016-11-11 |
F |
lowered | stable | expanding |
6/9 |
4/9 |
| Q2 2016 |
2016-08-18 |
C+ |
raised | stable | expanding |
6/9 |
3/9 |
| Q1 2016 |
2016-05-08 |
C+ |
maintained | accelerating | expanding |
7/9 |
2/9 |
| Q4 2015 |
2016-02-11 |
B |
raised | accelerating | contracting |
7/9 |
3/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of DTNOF's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
B+
Q4 2021 earnings call
2022-02-10
1 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← DTMXF All “D” companies
DTRM →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.